Welcome to our dedicated page for Stevanato Group S.p.A. SEC filings (Ticker: STVN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stevanato Group S.p.A. filings document the company’s reporting as a foreign private issuer and its business in drug containment, drug delivery and diagnostic solutions. Form 6-K reports furnish interim financial statements, results press releases, investor presentations and conference call materials covering revenue trends, segment performance, high-value solutions, margins, guidance, capacity expansion and risk disclosures.
Governance filings also include shareholder meeting notices, explanatory reports, sustainability reporting, committee reports, remuneration policy materials, dividend allocation matters and director slate information. These documents describe the company’s financial reporting framework, board and committee processes, shareholder voting matters and public-company disclosures for STVN.
Stevanato Group S.p.A. director Balachandran Madhavan reported routine equity compensation and related share sales. On June 12, 2026, he received 4,975 Ordinary Shares as equity compensation at $0.00 per share. On June 15, 2026, he sold 1,493 Ordinary Shares at $17.09 per share to cover tax obligations associated with this grant. After these transactions, he directly held 69,458 Ordinary Shares.
Stevanato Group S.p.A. Chief Financial Officer Marco Dal Lago reported several equity compensation transactions involving ordinary shares and restricted share units on June 12, 2026. He acquired 7,997 ordinary shares through an exercise or conversion of a derivative security and received an additional 2,356 ordinary shares as a grant or award.
These actions are tied to performance share units and restricted share units that vest based on service and performance periods running from January 2023 to December 2027. Following the largest reported transaction, Dal Lago directly holds 85,353 ordinary shares, reflecting his ongoing equity stake in Stevanato Group.
LIN SUE-JEAN reported acquisition or exercise transactions in this Form 4 filing.
Stevanato Group S.p.A. director Sue-Jean Lin received an equity compensation grant of 4,975 Ordinary Shares on June 12, 2026, at no cash cost per share. This award increased her directly held stake to 6,975 Ordinary Shares, reflecting stock-based compensation for her board service rather than an open-market purchase.
Stevanato Group S.p.A. director Donald E. Morel Jr. reported two transactions in Ordinary Shares. He received 4,975 shares as equity compensation for board service, then sold 1,493 shares at $17.09 per share to cover tax obligations tied to that grant. After these moves, he directly holds 37,424 shares.
Santel Luciano reported acquisition or exercise transactions in this Form 4 filing.
Stevanato Group S.p.A. director Luciano Santel received an award of 4,975 Ordinary Shares on June 12, 2026 as equity compensation for his board service. The shares were granted at no cash cost, increasing his direct holdings to 6,762 Ordinary Shares, according to the Form 4.
Magistretti Elisabetta reported acquisition or exercise transactions in this Form 4 filing.
Stevanato Group S.p.A. director Elisabetta Magistretti received a grant of 4,975 Ordinary Shares on June 12, 2026 as equity compensation for her board service. The shares were awarded at no cash cost to her and bring her directly held stake to 4,975 shares.
Stevanato Group S.p.A. officer Mauro Stocchi reported multiple equity compensation transactions in Ordinary Shares. On June 9, 2026, he acquired 6,586 Ordinary Shares at a price of $0.00 per share through the exercise of performance-based equity previously granted.
He also received a separate grant of 2,101 Ordinary Shares at $0.00 per share as an award. In addition, he exercised several tranches of Restricted Share Units, covering 2,053, 2,063 and 2,470 underlying Ordinary Shares. All reported transactions reflect share acquisitions related to compensation and equity awards, with no open‑market purchases or sales disclosed.
Stevanato Group S.p.A. director Karen Flynn reported a grant and related share sale. She received 4,975 Ordinary Shares as equity compensation for her service as a director, at a recorded price of $0.0000 per share. She then sold 1,493 Ordinary Shares at $17.09 per share to cover tax obligations associated with this grant. After these transactions, she directly holds 5,757 Ordinary Shares.
Stevanato Group S.p.A. director William J. Federici reported routine equity compensation and related share sales. On June 12, 2026, he received a grant of 4,975 Ordinary Shares as equity compensation for his board service, increasing his direct holdings to 28,484 shares.
On June 15, 2026, he sold 1,493 Ordinary Shares at $17.09 per share to cover tax obligations associated with this grant, leaving 26,991 Ordinary Shares held directly. A separate holding entry shows 31,589 Ordinary Shares held indirectly "by spouse and others" as of June 12.